Compare CRBU & BYND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRBU | BYND |
|---|---|---|
| Founded | 2011 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.3M | 117.8M |
| IPO Year | 2021 | 2018 |
| Metric | CRBU | BYND |
|---|---|---|
| Price | $0.54 | $7.13 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 6 | 3 |
| Target Price | $5.75 | ★ $12.50 |
| AVG Volume (30 Days) | ★ 4.7M | 1.1M |
| Earning Date | 11-11-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.64 | ★ 24.69 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $275,496,000.00 |
| Revenue This Year | $145.34 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.44 | $0.40 |
| 52 Week High | $3.53 | $15.47 |
| Indicator | CRBU | BYND |
|---|---|---|
| Relative Strength Index (RSI) | 24.76 | 40.71 |
| Support Level | $0.44 | $0.63 |
| Resistance Level | $1.72 | $12.52 |
| Average True Range (ATR) | 0.06 | 0.42 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 12.28 | 40.94 |
Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company is focused on advancing two clinical-stage allogeneic CAR-T cell therapy product candidates for the treatment of patients with hematologic malignancies: Vispacabtagene regedleucel and CB-011. It operates in one reportable segment, which is the business of developing allogeneic CAR-T cell therapies. Geographically, it operates in the United States and the rest of the World, of which the United States derives the maximum revenue.
Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.